We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Exscientia Plc (EXAI) ADS EACH REPR 1 ORD SH

Sell:$4.37 Buy:$4.39 Change: $0.015 (0.34%)
NASDAQ:0.03%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$4.37
Buy:$4.39
Change: $0.015 (0.34%)
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$4.37
Buy:$4.39
Change: $0.015 (0.34%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI platform includes Precision Target, Precision Design, Precision Experiment, Precision Medicine, Presentations and Publications. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Its advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.

Contact details

Address:
The Schrodinger Building
Oxford Science Park
OXFORD
OX4 4GE
United Kingdom
Telephone:
+44 (1865) 818941
Website:
https://www.exscientia.ai/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EXAI
ISIN:
US30223G1022
Market cap:
$587.09 million
Shares in issue:
251.82 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • David Hallett
    Interim Chief Executive Officer, Chief Scientific Officer
  • Ben Taylor
    Chief Financial and Strategy Officer, Director
  • Garry Pairaudeau
    Chief Technology Officer
  • Michael Krams
    Chief Quantitative Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.